Mounjaro (tirzepatide) is a dual-action medicine that targets both GLP-1 and GIP receptors, potentially offering enhanced weight loss effects
However, researchers sometimes use BPC-157 alongside GLP-1 therapies to address gastrointestinal side effects, given its demonstrated gastroprotective properties
I recorded a full breakdown of this story
Nausea, reflux, indigestion, diarrhea, and constipation can happen, especially early on or after dose increases
We get most of it from animal-derived products within our diet
The GLP-1 Patches are also perfect for individuals looking for convenient foot and leg comfort during long hours of standing or walking